BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34884928)

  • 21. The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma.
    He YH; Chen C; Shi Z
    J Cell Physiol; 2018 Jun; 233(6):4458-4465. PubMed ID: 29215721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
    Jiao M; Guo H; Chen Y; Li L; Zhang L
    Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
    Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
    Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
    Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
    Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
    Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X
    Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma.
    Braga EA; Fridman MV; Filippova EA; Loginov VI; Pronina IV; Burdennyy AM; Karpukhin AV; Dmitriev AA; Morozov SG
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.
    Cox A; Tolkach Y; Kristiansen G; Ritter M; Ellinger J
    Clin Transl Oncol; 2020 Sep; 22(9):1524-1531. PubMed ID: 31965534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter-based identification of novel non-coding RNAs reveals the presence of dicistronic snoRNA-miRNA genes in Arabidopsis thaliana.
    Qu G; Kruszka K; Plewka P; Yang SY; Chiou TJ; Jarmolowski A; Szweykowska-Kulinska Z; Echeverria M; Karlowski WM
    BMC Genomics; 2015 Nov; 16():1009. PubMed ID: 26607788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma.
    Liu X; Xie W; Meng S; Kang X; Liu Y; Guo L; Wang C
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
    Qian M; Zheng JL; Kang N; Su YL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
    Mehdi A; Riazalhosseini Y
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. snoRNAs Offer Novel Insight and Promising Perspectives for Lung Cancer Understanding and Management.
    Mourksi NE; Morin C; Fenouil T; Diaz JJ; Marcel V
    Cells; 2020 Feb; 9(3):. PubMed ID: 32111002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma.
    Cheng G; Yu Y; Wang L; Pan Q
    Aging (Albany NY); 2020 Apr; 12(8):7448-7464. PubMed ID: 32315986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.
    Malouf GG; Zhang J; Yuan Y; Compérat E; Rouprêt M; Cussenot O; Chen Y; Thompson EJ; Tannir NM; Weinstein JN; Valero V; Khayat D; Spano JP; Su X
    Mol Oncol; 2015 Jan; 9(1):32-43. PubMed ID: 25126716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.